University of California, Los Angeles

Return to Grants

Total Awards:
163
Award Value:
$444,763,314
Institution type:
Not for profit
Short Name:
UCLA

Awards to the Institution

Program Type Investigator Grant Title Award Value
Shared Labs Grant – Enhancing/Expanding SRLs Dr. Kathrin Plath Dr. A modular automation approach to stem cell modeling to increase throughput, reproducibility and access $3,999,999
Manufacturing Network Grant Dawn Ward Enhancing California’s Manufacturing of Leading-Edge Cell & Gene Therapies $2,000,000
Foundation – Discovery Stage Research Projects Dr. M. Carrie Miceli Interrogating Satellite Cell and Myofiber Defects and Repair in Human DMD using Single Nuclei/Single Cell RNA Sequencing of Muscle Resident Cells $1,578,000
Foundation – Discovery Stage Research Projects Michael F Wells Village-based identification of human risk factors for viral neuropathogenesis $1,577,448
Foundation – Discovery Stage Research Projects Dr. William Lowry Dr. Defining the source of dysfunction in monogenic Intellectual Disability Syndrome neurons $1,500,337
Foundation – Discovery Stage Research Projects Dr. Kathrin Plath Dr. Characterization and applications of human blastoids for understanding early human embryogenesis $1,402,137
Foundation – Discovery Stage Research Projects Dr. Brigitte N Gomperts Overcoming barriers for airway stem cell gene therapy for Cystic Fibrosis $1,472,858
Foundation – Discovery Stage Research Projects Dr. Gay Miriam Crooks Engineering pluripotent stem cells for universally available, off-the-shelf T cell therapies $1,352,753
Foundation – Discovery Stage Research Projects Dr Melissa Jan Spencer Engineering AAV capsids for transduction of neural and muscle stem cells $999,999
COMPASS Training Grant Tracy L Johnson COMPASS: Accelerating Stem Cell Research by Educating and Empowering New Stem Cell Researchers $2,910,000
Research Training Grant William Lowry UCLA Training Program in Stem Cell Biology $5,373,742
Therapeutic Translational Research Projects Dr. Vaithilingaraja Arumugaswami PhD COVID-19 Antiviral Therapy to Block Direct Cell Injury and Associated Tissue Damage $349,999
Discovery Research Projects Dr. Lili Yang Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells $250,000
Discovery Research Projects Prof. Song Li Biomaterial vaccine to enhance the formation of SARS-CoV-2-specific T memory stem cells $149,916
Discovery Research Projects Dr. Gay Miriam Crooks Stem cell-based rapid identification of SARS-CoV-2 T cell epitopes and T cell receptors for therapeutic use $126,692
Discovery Research Projects Dr. Brigitte N Gomperts Identifying a lead compound for COVID19 using high throughput screening with lung stem cell organoids $149,998
Progression Award – Discovery Stage Research Projects Dr. Caroline Y. Kuo Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8 $234,000
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium John S. Adams Delivery of Stem Cell Therapeutics to Patients $60,000
Alpha Stem Cell Clinics Network Expansion Dr. Noah Carvajal Federman Expansion of the Alpha Stem Cell and Gene Therapy Clinic at UCLA $8,000,000
Conference – Lung Regenerative Medicine Workshop Dr. Brigitte N Gomperts Stem Cells for Lung Diseases – Overcoming Barriers to Find New Therapies $44,548
Quest – Discovery Stage Research Projects Prof. Song Li Vax-CT to promote formation of cancer-specific T memory stem cell for personalized cancer immunotherapy $2,267,714
Quest – Discovery Stage Research Projects Dr. Richard Joseph Pietras Reversal of dysregulated myelopoiesis in breast cancers and cancer stem cells to boost antitumor immunotherapy $2,327,680
Quest – Discovery Stage Research Projects Dr. Gerald Lipshutz Gene Therapy for SLC6A8 Creatine Transporter Disorder $2,296,920
Quest – Discovery Stage Research Projects Frank Pajonk Development of novel small molecules against cancer stem cells in solid cancers $2,340,000
Quest – Discovery Stage Research Projects Dr. Lili Yang Combating Ovarian Cancer Using Stem Cell-Engineered Off-The-Shelf CAR-iNKT Cells $1,404,000
Quest – Discovery Stage Research Projects Dr. Xian-Jie Yang Developing gene therapy for dominant optic atrophy using human pluripotent stem cell-derived retinal organoid disease models $1,345,691
Quest – Discovery Stage Research Projects Dr Dinesh S Rao Novel methods to eliminate cancer stem cells $1,384,347
Quest – Discovery Stage Research Projects Dr. Caroline Y. Kuo Defining the Optimal Gene Therapy Approach of Human Hematopoietic Stem Cells for the Treatment of Dedicator of Cytokinesis 8 (DOCK8) Deficiency $1,386,232
Quest – Discovery Stage Research Projects Dr. Mona AuYoung PhD Hematopoietic Stem Cell Gene Therapy for Alpha Thalassemia $1,177,739
Quest – Discovery Stage Research Projects Prof. Song Li iPSC Extracellular Vesicles for Diabetes Therapy $1,354,928
Quest – Discovery Stage Research Projects Dr. Thomas Carmichael M.D., Ph.D. Human-induced pluripotent stem cell-derived glial enriched progenitors to treat white matter stroke and vascular dementia. $250,000
Quest – Discovery Stage Research Projects Dr. Mona AuYoung PhD Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia $219,230
Quest – Discovery Stage Research Projects Dr. Lili Yang Preclinical Development of An HSC-Engineered Off-The-Shelf iNKT Cell Therapy for Cancer $1,404,000
Quest – Discovery Stage Research Projects Dr. Scott G Kitchen Engineering Lifelong Cellular Immunity to HIV $1,701,178
Quest – Discovery Stage Research Projects Dr. Thomas Carmichael M.D., Ph.D. iPS Glial Therapy for White Matter Stroke and Vascular Dementia $2,086,130
Quest – Discovery Stage Research Projects Dr. April Pyle Ph.D. Identification and Generation of Long Term Repopulating Human Muscle Stem Cells from Human Pluripotent Stem Cells $2,148,519
Quest – Discovery Stage Research Projects Dr. Vaithilingaraja Arumugaswami PhD Immunization strategies to prevent Zika viral congenital eye and brain disease $2,128,867
Quest – Discovery Stage Research Projects UCLA Gay M Crooks Platform Technology for Pluripotent Stem Cell-Derived T cell Immunotherapy $965,636
Quest – Discovery Stage Research Projects Dr. Caroline Y. Kuo Targeted Gene Editing in the Treatment of X-Linked Hyper-IgM Syndrome $1,512,333
Quest – Discovery Stage Research Projects Dr. John P Chute Protein tyrosine phosphatase – sigma inhibitors for hematopoietic regeneration $2,115,735
Quest – Discovery Stage Research Projects Dr. April Pyle Ph.D. CRISPR/Cas9 nanoparticle enabled therapy for Duchenne Muscular Dystrophy in muscle stem cells $2,150,400
Inception – Discovery Stage Research Projects Alireza Moshaverinia Gingival mesenchymal stem cells as a novel treatment modality for periodontal tissue regeneration $194,483
Inception – Discovery Stage Research Projects Dr. Owen N Witte M.D. Identification of stem cell surface markers as potential therapeutic targets for advanced prostate cancer $209,160
Inception – Discovery Stage Research Projects Dr. April Pyle Ph.D. Novel Platforms to Enhance In Vivo Delivery of Skeletal Muscle Progenitor Cells from Human Pluripotent Stem Cells $230,400
Inception – Discovery Stage Research Projects Dr. Bennett G Novitch Ph.D. Organoid Modeling of Human Cortical Microcircuits $208,916
Inception – Discovery Stage Research Projects Dr. Arjun Deb Targeting progenitors in scar tissue to reduce chronic scar burden $230,400
Inception – Discovery Stage Research Projects Dr. Thomas Carmichael M.D., Ph.D. iPS-Interneuron Transplantation for Neural Repair after Stroke $229,396
Therapeutic Translational Research Projects Dr. Lili Yang Combating Ovarian Cancer with Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy $6,312,000
Therapeutic Translational Research Projects Dr. Gerald Lipshutz DDS, MD, MS Development of a Gene Therapy for Treatment of Guanidinoacetate Methyltransferase Deficiency-Translating In Vivo Proof of Concept to Support a Pre-IND $5,145,825
Therapeutic Translational Research Projects Zulema Romero Garcia Adenine Base Editing for Autologous Hematopoietic Stem Cell Gene Therapy of CD3δ SCID $5,966,928
Therapeutic Translational Research Projects Dr. Donald B Kohn Hematopoietic Stem Cell Gene Editing for X-linked Agammaglobulinemia (XLA) $4,309,973
Therapeutic Translational Research Projects Dr. Gerald Lipshutz DDS, MD, MS Development of a Gene Therapy for the Treatment of Arginase Deficiency – Translating from Proof of Concept to Support Pre-IND Meeting $5,266,504
Therapeutic Translational Research Projects Anthony J Aldave AAV Gene Therapy for Treating Congenital Hereditary Endothelial Dystrophy associated with Biallelic SLC4A11 Mutations $4,338,166
Therapeutic Translational Research Projects Dr. Sophie X Deng Extracellular Vesicle-Based Therapy for Corneal Scars $5,779,276
Therapeutic Translational Research Projects Dr. Scott G Kitchen Hematopoietic Stem/Progenitor Cell-Based Chimeric Antigen Receptor Gene Therapy for HIV Infection $6,140,723
Therapeutic Translational Research Projects Dr. Mona AuYoung PhD Autologous MPO Knock-Out Hematopoietic Stem and Progenitor Cells for Pulmonary Arterial Hypertension $4,751,297
Therapeutic Translational Research Projects Dr. Arjun Deb Targeting stromal progenitors to prevent the development of heart failure $4,714,824
Therapeutic Translational Research Projects Dr. Irene L. Llorente Clinical Translation of Allogenic Regenerative Cell Therapy for White Matter Stroke and Vascular Dementia $707,754
Therapeutic Translational Research Projects Cristina Puig Saus CAR-Tnm cell therapy for melanoma targeting TYRP-1 $5,904,462
Therapeutic Translational Research Projects Dr. Lili Yang HSC-Engineered Off-The-Shelf CAR-iNKT Cell Therapy for Multiple Myeloma $5,281,199
Therapeutic Translational Research Projects Yvonne Y. Chen BCMA/CS1 Bispecific CAR-T Cell Therapy to Prevent Antigen Escape in Multiple Myeloma $3,176,805
Therapeutic Translational Research Projects Dr. Caroline Y. Kuo Ex Vivo Gene Editing of Human Hematopoietic Stem Cells for the Treatment of X-Linked Hyper-IgM Syndrome $4,896,628
Therapeutic Translational Research Projects Steven Schwartz Clinical Translation of Autologous Regenerative Cell Therapy for Blindness $5,068,026
Therapeutic Translational Research Projects Dr. Peter Cawood Butler Personalized Cell Therapy for Diabetes $1,494,896
Therapeutic Translational Research Projects Dr. Lili Yang Stem Cell-Based iNKT Cell Therapy for Cancer $6,956,775
Conference II Mark Wisniewski Los Angeles Bioscience Ecosystem Summit Twenty 24 (LABEST 24) $50,000
Conference II Song Li The 18th Annual UC System-Wide Bioengineering Symposium $25,000
Conference II Dr. Mona AuYoung PhD Primary Immune Deficiency Treatment Consortium (PIDTC) Annual Scientific Workshop $29,807
Clinical Trial Stage Projects Dr. Sophie X Deng Safety and Feasibility of Cultivated Autologous Limbal Stem Cells for Limbal Stem Cell Deficiency $10,301,486
Clinical Trial Stage Projects Theodore Scott Nowicki Genetic Modification of Stem Cells and T cells to Activate the Immune System to Target Solid Tumors $4,230,000
Clinical Trial Stage Projects Dr. Steven M. Dubinett MD A phase I trial of intratumoral administration of CCL21-gene modified dendritic cell (DC) combined with intravenous pembrolizumab for advanced NSCLC $10,955,315
Clinical Trial Stage Projects Dr. Mona AuYoung PhD Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects $5,827,000
Clinical Trial Stage Projects Dr. Donald B Kohn Efficacy and safety of cryopreserved autologous CD34+ HSC transduced with EFS lentiviral vector encoding for human ADA gene in ADA-SCID subjects $10,156,925
Clinical Trial Stage Projects Dr. Mona AuYoung PhD A Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease $7,083,364
Late Stage Preclinical Projects Dr. Arjun Deb Development of a therapeutic monoclonal antibody for the treatment of myocardial infarction and heart failure $5,999,998
Late Stage Preclinical Projects Dr. Jerome A. Zack Ph.D. Clinical Translation of Autologous Regenerative Pluripotent Stem Cell Therapy for Blindness $6,000,000
Late Stage Preclinical Projects Dr. Antoni Ribas MD/PhD Skin regeneration and wound healing with a topical BRAF inhibitor $5,005,126
Late Stage Preclinical Projects Dr. Sophie X Deng Regeneration of a Normal Corneal Surface by Limbal Stem Cell Therapy $4,244,211
Alpha Stem Cell Clinics John S. Adams UCLA-UCI Alpha Stem Cell Clinic (ASCC) Consortium $8,680,000
Tools and Technologies III Dr. James C. Dunn Dr. Skin-derived precursor cells for the treatment of enteric neuromuscular dysfunction $1,044,423
Tools and Technologies III Dr. Hanna Mikkola A suite of engineered human pluripotent stem cell lines to facilitate the generation of hematopoietic stem cells $1,382,400
Tools and Technologies III Dr. Carla M. Koehler A small molecule tool for reducing the malignant potential in reprogramming human iPSCs and ESCs $1,283,900
Tools and Technologies III Leif Havton Development of a Relevant Pre-Clinical Animal Model as a Tool to Evaluate Human Stem Cell-Derived Replacement Therapies for Motor Neuron Injuries and Degenerative Diseases $1,308,711
Conference Dr. Martina Wiedau-Pazos California ALS Summit 2011 $13,300
Conference Dr. Tatiana Segura 2013 Materials Research Society (MRS) Spring Meeting Symposium “Design of Cell Instructive Materials” $4,000
Conference Dr. Irvin SY Chen Stem Cells: A New Avenue of HIV Research and New Approaches to HIV Treatment $24,456
Conference Dr. Dana Leanne Jones 7th CA/HSCI Junior PI Conference: Stem Cells 2.0 $2,500
Disease Team Planning Dr. Irvin SY Chen Stem Cell Therapy for AIDS- Disease Team Planning $51,490
Disease Team Planning Dr. Stanley Thomas Carmichael Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke $42,748
Major Facilities Dr. Gene D. Block UCLA CIRM Institute $19,854,900
Basic Biology V Dr. Bennett G Novitch In vitro modeling of human motor neuron disease $1,148,758
Basic Biology V Dr Samantha J Butler Ph.D. Assessing the mechanism by which the Bone Morphogenetic Proteins direct stem cell fate $515,730
Basic Biology V Dr. Denis A Evseenko Dr. Promoting survival and countering hypertrophy of pluripotent stem cell (PSC)-derived chondrocytes $411,330
Basic Biology V Dr. Lili Yang Differentiation of Human Hematopoietic Stem Cells into iNKT Cells $614,400
Disease Team Therapy Development III Dr. Dennis J Slamon A Phase I dose escalation and expansion clinical trial of the novel first-in-class Polo-like Kinase 4 (PLK4) inhibitor, CFI-400945 in patients with advanced solid tumors $5,683,693
Disease Team Therapy Development III Dr. Mona AuYoung PhD Clinical Trial of Stem Cell Gene Therapy for Sickle Cell Disease $13,145,465
Patent Assistance Fund Awards Adele Rennie Patent Assistance Fund – UCLA $84,973
Early Translational from Disease Team Conversion Dr. Irvin SY Chen Development of a humanized mouse model for testing anti-HIV HSPC gene therapy strategies in HIV-1 infected mice. $1,505,000
Early Translational from Disease Team Conversion Dr. Stanley Nelson Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $1,823,545
Early Translational IV Dr. Robert Reiter MD Clinical Development of an N-cadherin Antibody to Target Cancer Stem Cells $4,075,668
Early Translational IV Dr. Jerome A. Zack Ph.D. Stem Cell Programming With Chimeric Antigen Receptors to Eradicate HIV Infection $4,925,166
Early Translational IV Dr. Gerald Lipshutz Gene therapy-corrected autologous hepatocyte-like cells from induced pluripotent stem cells for the treatment of pediatric single enzyme disorders $1,801,629
Early Translational IV Dr. Mona AuYoung PhD Beta-Globin Gene Correction of Sickle Cell Disease in Hematopoietic Stem Cells $1,651,884
Tissue Collection for Disease Modeling Dr. Brigitte N Gomperts Using human induced pluripotent stem cells to improve our understanding of Idiopathic Pulmonary Fibrosis $811,231
New Faculty Physician Scientist Dr. Ali Nsair MD Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. $2,316,894
New Faculty Physician Scientist Dr. Reza Ardehali MD, PhD Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors in a large animal model $2,930,388
Basic Biology IV Dr. Owen N Witte M.D. Trop2 dependent and independent mechanisms of self-renewal in human cancer stem cells $1,254,960
Basic Biology IV Dr. Kathrin Plath Dr. Understanding the status of the X chromosomes in human ESCs and preimplantation embryos $1,382,400
Disease Team Therapy Development – Research Dr. Antoni Ribas MD/PhD Genetic Re-programming of Stem Cells to Fight Cancer $14,144,221
Disease Team Therapy Development – Research Dr. Stanley Nelson Combination Therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $0
Training Grant I-1 Dr. Owen N Witte M.D. CIRM Type I Comprehensive Training Program $3,660,398
Disease Team Therapy Planning I Dr. Stanley Nelson Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy $68,947
Disease Team Therapy Planning I Dr. Antoni Ribas MD/PhD Genetic Re-programming of Stem Cells to Fight Cancer $97,785
Research Training II Kenneth Dorshkind UCLA CIRM Research Training Program II $7,790,488
Basic Biology III Dr. Yi Eve Sun Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo $1,382,400
Basic Biology III Dr. Kathrin Plath Dr. Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells $1,364,598
Basic Biology III Dr. Ali Nsair MD Characterization and Engineering of the Cardiac Stem Cell Niche $1,127,741
Basic Biology III Dr. William Lowry Dr. Molecular determinants of accurate differentiation from human pluripotent stem cells $677,115
Basic Biology III Dr. Shuo Lin Dr. Etsrp/ER71 mediated stem cell differentiation into vascular lineage $1,378,781
Basic Biology III Dr. Gay Miriam Crooks Forming the Hematopoietic Niche from Human Pluripotent Stem Cells $1,252,857
Tools and Technologies II Dr. Richard A. Gatti Use of hiPSCs to develop lead compounds for the treatment of genetic diseases $1,833,054
Tools and Technologies II Dr. Thomas Carmichael M.D., Ph.D. Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke $1,825,613
Tools and Technologies II Dr. Martin Gabriel Martin Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders $1,783,250
Early Translational II Dr. Sophie X Deng Regeneration of Functional Human Corneal Epithelial Progenitor Cells $697,507
Early Translational II Dr. Sophie X Deng Regeneration of Functional Human Corneal Epithelial Progenitor Cells $1,524,947
Early Translational II Leif Havton Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $75,628
Early Translational II Dr. Noriyuki Kasahara Stem cell-based carriers for RCR vector delivery to glioblastoma $3,340,625
Early Translational II Prof. Bruno Peault Harnessing native fat-residing stem cells for bone regeneration $5,359,076
Research Leadership Dr. John P Chute Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors $4,645,297
New Faculty I Dr. Dana Leanne Jones Characterization of mechanisms regulating de-differentiation and the re-acquisition of stem cell identity $382,773
New Faculty I Dr. Siavash Kurdistani Epigenetics in cancer stem cell initiation and clinical outcome prediction $3,063,450
New Faculty I Dr. Kathrin Plath Dr. In vitro reprogramming of mouse and human somatic cells to an embryonic state $2,229,427
New Faculty I Dr. Hanna Mikkola Mechanisms of Hematopoietic stem cell Specification and Self-Renewal $2,286,900
Early Translational I Dr. Gabriel H. Travis Development of a Stem Cell-based Transplantation Strategy for Treating Age-related Macular Degeneration $5,487,136
Transplantation Immunology Dr. Gay Miriam Crooks Engineering Thymic Regeneration to Induce Tolerance $1,235,445
Tools and Technologies I Dr. Michael E. Phelps Novel Tools and Technologies for Translational PET Imaging of Cell-based Therapies $914,039
Tools and Technologies I Dr. Hsian-Rong Tseng Microfluidic Platform for Screening Chemically Defined Conditions that Facilitate Clonal Expansion of Human Pluripotent Stem Cells $914,096
Shared Labs Scott Waugh CIRM Shared Research Laboratories $2,000,000
Shared Labs Dr. Owen N Witte M.D. CIRM Shared Research Laboratories $1,751,297
New Faculty II Dr. Antoni Ribas MD/PhD Stem Cells for Immune System Regeneration to Fight Cancer $3,072,000
New Faculty II Dr. Brigitte N Gomperts Stem Cells in Lung Cancer $2,381,572
New Cell Lines Dr. Jerome A. Zack Ph.D. Generation of clinical grade human iPS cells $1,341,000
New Cell Lines Dr. Amander Clark Dr. Generation of Pluripotent Cell Lines from Human Embryos $1,167,416
Comprehensive Grant Dr. Jerome A. Zack Ph.D. Human Embryonic Stem Cell Therapeutic Strategies to Target HIV Disease $2,401,903
Comprehensive Grant Dr. Gay Miriam Crooks Regulated Expansion of Lympho-hematopoietic Stem and Progenitor Cells from Human Embryonic Stem Cells (hESC) $1,653,416
Comprehensive Grant Dr. Guoping Fan Dr. Epigenetic gene regulation during the differentiation of human embryonic stem cells: Impact on neural repair $2,412,995
SEED Grant Dr. Noriyuki Kasahara Down-Regulation of Alloreactive Immune Responses to hES Cell-Derived Graft Tissues $399,239
SEED Grant Dr. Hanna Mikkola Improving microenvironments to promote hematopoietic stem cell development from human embryonic stem cells $550,241
SEED Grant Dr. William Lowry Dr. Modeling Human Embryonic Development with Human Embryonic Stem Cells $528,096
SEED Grant Dr. Siavash Kurdistani Cellular epigenetic diversity as a blueprint for defining the identity and functional potential of human embryonic stem cells $549,698
SEED Grant Dr. Zoran Galic Genetic Enhancement of the Immune Response to Melanoma via hESC-derived T cells $616,800
SEED Grant Dr. Irvin SY Chen Genetic modification of the human genome to resist HIV-1 infection and/or disease progression $616,800
SEED Grant Dr. Michael A. Teitell Role of Mitochondria in Self-Renewal Versus Differentiation of Human Embryonic Stem Cells $543,274
Basic Biology II Dr. Douglas L. Black Programs of alternative splicing regulation by polypyrimidine tract binding protein $1,344,562
Basic Biology II Dr. Benhur Lee The EphrinB2/EphB4 axis in regulating hESC pluripotency and differentiation $1,371,936
Basic Biology II Dr. Yong Kim Novel Mechanism in Self-Renewal/Differentiation of Human Embryonic Stem Cells $1,259,371
Disease Team Research I Dr. Mona AuYoung PhD Stem Cell Gene Therapy for Sickle Cell Disease $8,833,695
Disease Team Research I Dr. Irvin SY Chen HPSC based therapy for HIV disease using RNAi to CCR5. $9,905,604
Disease Team Research I Dr. Dennis J Slamon Therapeutic Opportunities To Target Tumor Initiating Cells in Solid Tumors $19,979,660
Basic Biology I Dr. Michael A. Teitell Mitochondrial Metabolism in hESC and hiPSC Differentiation, Reprogramming, and Cancer $1,323,029
Basic Biology I Dr. Bennett G Novitch Ph.D. Molecular Characterization of hESC and hIPSC-Derived Spinal Motor Neurons $1,228,278
Basic Biology I Dr. Robb Maclellan Dr. Human Cardiovascular Progenitors, their Niches and Control of Self-renewal and Cell Fate $917,667
Basic Biology I Dr. Luisa Iruela-Arispe Molecular Characterization and Functional Exploration of Hemogenic Endothelium $1,371,477
Total:
$444,763,313.95